Author: openjargon

The recent changes to capital gains tax (CGT) may reduce the after-tax appeal of investment returns driven by share-price growth. 

This is influencing some investors to favour ASX dividend shares. That’s because a greater portion of returns comes from regular income and potentially franking credits.

According to S&P research, the trailing 12-month dividend yield of the S&P/ASX 300 Index (ASX: XKO) is around 3.5%.

For investors looking to outperform this benchmark, here are three ASX dividend shares with yields over 6%. 

Rural Funds Group (ASX: RFF)

Rural Funds Group is a real estate investment trust (REIT) that holds and leases agricultural land and equipment. 

The company manages around $2 billion of diversified farmland and assets located across several states.

Its segments include cattle, almonds, macadamias, cropping, vineyards, and other agricultural products. The majority of its revenue is derived from its cattle and almond segments.

ASX REITs can be attractive dividend stocks because they typically own income-producing property and distribute a significant portion of rental income to investors as distributions. 

Their returns can therefore provide relatively predictable income. It is worth considering dividends are not guaranteed as REITs can be sensitive to interest rates, property values and debt costs.

At the time of writing, this ASX dividend stock is offering a distribution per unit of 11.73 cents in FY27, which is a yield of approximately 6%.

IPH Ltd (ASX: IPH)

IPH is a holding company, which engages in the provision of intellectual property (IP) services.

This is attractive as a dividend stock because it has a defensive, recurring business, strong cash generation, and a history of growing its dividend. 

IPH is considered defensive because businesses still need to protect and maintain their patents and trademarks regardless of the economic cycle. Once a company has an IP portfolio, it generally continues paying for renewals, legal work and administration even during a recession.

So IPH’s revenue is less dependent on people buying discretionary products or services, which can make its cash flows and dividends more stable than those of many other companies.

At the current share price, the recent dividends imply a very high yield of over 11%. 

HomeCo Daily Needs REIT (ASX: HDN)

Another ASX dividend stock to target for high yields is HomeCo Daily Needs. 

Another ASX REIT, it is an Australian property group focused on the ownership, development, and management of Australian shopping centres.

It also offers a defensive profile, as its property focuses on everyday needs such as supermarkets, healthcare, childcare and essential services. 

These tenants tend to remain in demand even when the economy weakens, which supports relatively stable rental income and distributions.

At the time of writing, it offers a yield over 7%. 

The post 3 ASX dividend shares with yields over 6% appeared first on The Motley Fool Australia.

More reading

• How much do I need to retire on $80,000 a year at 50?
• 2 great ASX dividend share buys for passive income in September
• 3 ASX passive income stocks to buy with $50,000
• 3 top ASX dividend shares to buy in September
• How much is needed in superannuation to target a $60,000 annual passive income?

Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Rural Funds Group. The Motley Fool Australia has recommended HomeCo Daily Needs REIT and IPH Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Choosing ASX dividend shares gets harder when the cash rate is looking like increasing.

All four major banks now expect the Reserve Bank to tighten again this year.

A term deposit paying close to 5% becomes a competitor for income money.

The three companies below each deal with that problem in different ways.

1. Macquarie Group Ltd (ASX: MQG)

Macquarie Group is the one of the few companies that benefits from higher rates.

The company earns on client cash balances, and its markets businesses tend to do better when volatility rises.

FY26 net profit rose 30% to $4.85 billion and earnings per share climbed 30% to $12.77.

Return on equity recovered to 14.0% and assets under management reached $748 billion.

The full-year dividend was $7.00 per share, though franked at only 35%.

Today, the shares trade on a price-to-earnings ratio near 19.9 with a 2.78% yield.

The trade-off is a dividend that grows with earnings.

2. Transurban Group (ASX: TCL)

Transurban Group is the classic rate-sensitive income stock, and it has been treated accordingly.

The shares closed at $13.63, within a few cents of a 52-week low, and are down 4.82% over twelve months.

The trailing yield is 5.01%.

Despite all of this, the company’s operating result was solid.

Proportional toll revenue rose 6.7% to $3,982 million and proportional EBITDA rose 7.5% to $3,063 million.

Free cash increased 5.1% to $2,111 million.

The FY26 distribution was 69.0 cents per security, up 6.2%, and management has guided to 72 cents in FY27.

Proportional drawn debt sits at $27.1 billion with gearing of 37.4%.

The weighted average cost of Australian dollar debt is 4.8% and 87.8% of debt is hedged.

That hedging is what buys the company time if rates keep climbing.

Toll escalation is linked to inflation, so the same forces pushing rates higher also lift Transurban’s revenue.

Chief executive Michelle Jablko noted that despite the macroeconomic backdrop the group’s roads proved relatively resilient through the year.

3. APA Group (ASX: APA)

APA Group has been the best performer of the three, rising 22.23% over twelve months to $10.83.

The company’s dividend yield is 5.32%, though franked at only about 31%.

FY26 underlying EBITDA rose 8.3% to $2,183 million, above the midpoint of guidance.

Free cash flow rose 3.2% to $1,118 million and the distribution lifted 1.8% to 58.0 cents per security.

FY27 guidance calls for EBITDA of $2,260 million to $2,340 million and a 59.0 cent distribution.

The organic growth pipeline has expanded to roughly $3.5 billion.

Chief executive Adam Watson summed it up.

Our underlying earnings were up 8.3% and above the mid-point of guidance, supported by new assets and ongoing strong operational performance.

The catch is the price.

Brokers are split between hold and sell ratings, with an average target below the current share price.

Foolish takeaway

The instinct when rates rise is to sell every yield stock in sight.

That is too blunt, because these three respond to the same cash rate in opposite directions.

I would rather own a 5% distribution that grows with inflation than a term deposit that does not.

Transurban is the ASX dividend shares idea I find most interesting today, purely because the market has already marked it down.

Macquarie is the one I would be happiest holding if the Reserve Bank continues to look to increase rates.

The post Top 3 ASX dividend shares to buy if interest rates go up appeared first on The Motley Fool Australia.

More reading

• Top 3 ASX shares to buy with $3,000 in September
• How much is needed in superannuation for $3,000 in weekly passive income?
• 3 ASX passive income stocks to buy with $50,000
• These ASX shares benefit from a high Aussie dollar
• 3 stellar ASX dividend stocks to supplement your superannuation 

Motley Fool contributor Mark Verhoeven has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and Transurban Group. The Motley Fool Australia has positions in and has recommended Apa Group and Transurban Group. The Motley Fool Australia has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Fresh commentary from the team at Morgans has identified an exciting exploration-stage mining growth stock investors should be adding to their watchlist. 

The company in question is G50 Corp Ltd (ASX: G50). 

Company overview

G50 Corp was established to identify and advance opportunities involving economically viable precious metal deposits across the United States.

The Company’s flagship Golconda Project, situated in northwestern Arizona, represents its most advanced exploration asset. The project encompasses a number of historically worked, small-scale precious and polymetallic mines, positioned directly southeast of a significant porphyry copper-molybdenum system.

In central Nevada, Gold 50 holds the Spitfire, Broken Hills, Top Gun and Caisson Projects, each offering further exploration potential.

Despite limited modern exploration across these properties, all four projects exhibit evidence of gold mineralisation at surface. In particular, the Spitfire Project has recorded exceptionally high-grade, or “bonanza-grade,” gold and silver mineralisation.

As is typical with small-cap shares, it has experienced volatility in 2026. 

At the time of writing, its share price is down 35% year to date. 

For comparison, the S&P/ASX Small Ordinaries (ASX: XSO) index is down 8% in the same period, while the S&P/ASX 200 Index (ASX: XJO) is up 2%.

However, Morgans is bullish this exciting growth stock could be set to explode. 

Strong momentum

According to Morgans, G50 is making progress across its projects. 

Recent exploration has expanded the Golconda mineral system and identified high-grade gold at White Caps. 

The Company is also exploring ways to develop and potentially generate revenue from its gallium resources, which could benefit from growing demand for critical minerals.

G50 recently raised additional funding through a placement led by Hancock. 

This gives the Company the money it needs to increase exploration, develop its gallium opportunities and continue work on the larger Golconda project, including future funding and permitting requirements.

G50 continues to unlock value across its asset base, with recent activity extending the Golconda system, delivering a high-grade gold discovery at White Caps, and advancing potential gallium development pathways amid an increasingly supportive backdrop for critical minerals.

Big upside for this growth stock

Based on this guidance, Morgans has a $1.94 price target and speculative buy recommendation on G50 shares. 

From current levels, this indicates an upside of 321%. 

Following the recent Hancock-cornerstoned placement, the Company is well funded to accelerate exploration and advance potential gallium monetisation pathways, supporting early cash flow, financing and permitting for the broader Golconda deposit. We maintain our SPECULATIVE BUY rating with a target price of A$1.94ps.

The post Could this exciting growth stock be set to triple? Morgans thinks it can appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• The ASX 200 has dropped to a 3-day low. Here’s what’s happening
• Are NAB, ANZ, Westpac and CBA shares attractive buys right now?
• 5 things to watch on the ASX 200 on Tuesday
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

June 3 would have been an excellent day to channel your inner Warren Buffett and buy CSL Ltd (ASX: CSL) shares.

Of the many investment quotes Buffett is famous for, perhaps the best known is, “Be greedy when others are fearful.”

Indeed, on 3 June, a lot of investors were fearful about buying the S&P/ASX 200 Index (ASX: XJO) biotech giant, after it closed at a more than nine-year low.

Why did CSL shares crash to a multi-year low?

The CSL share price decline began in mid-2024 and ran for roughly two years.

Over this time the company issued a number of earnings downgrades, partly driven by lower than forecast plasma demand.

Vaccine uptakes in the United States also slumped, right about when management announced their plan to spin off the CSL Seqirus segment, its influenza vaccine business, into a separate ASX-listed company. (That plan remains on hold at the moment.)

Investors also reacted negatively to former CSL CEO Paul McKenzie’s unexpected exit in February this year.

Which brings us back to the closing bell on June 3, when you could have picked up CSL for just $92.24 a share.

Investing $10,000 into the ASX 200 healthcare share

If you’d embraced your inner Warren Buffett and invested $10,000 in the ASX 200 biotech stock on 3 June, you could have picked up 108 shares with a bit of pocket money left over.

On Tuesday, CSL shares were trading for $171.66 apiece. And if you held the stock through to market close, you’d also have received the final CSL dividend of $2.277 a share.

The stock is trading ex-dividend today.

So, if we add that passive income payout back into the recent share price, then the accumulated value of the shares you picked up for $92.24 on June 3 works out to (a rounded) $173.94 each.

Meaning the 108 shares you acquired for $10,000 just over three months ago would be worth $18,786 today.

Or a gain of 87.9%.

What’s sent the CSL shares rocketing?

By 17 August, shares in the ASX 200 healthcare stock had recovered to $134.60 as investors began to bet on the success of the company’s ‘reset’ process.

Then on 18 August, CSL shares rocketed 17.3% following the release of the company’s full-year FY 2026 results.

While revenue declined 1% year on year and CSL reported a net loss after tax of US$2.6 billion, the company forecast steady revenue in FY 2027 and underlying NPAT growth of around 5%.

“FY26 has been a year of reset. We have taken decisive action and created a clear path to return to sustainable growth,” CSL interim CEO Gordon Naylor said on the day of the results release.

The post $10,000 invested in CSL shares in June is now worth… appeared first on The Motley Fool Australia.

More reading

• Forget CSL shares. 3 ASX healthcare stocks with bigger upside
• If I invest $10,000 in CSL shares, what passive income will I earn in FY27?
• UBS names its 10 top ASX picks for the next 3-6 months
• Are CSL shares still cheap after almost doubling since June?
• CSL led the ASX healthcare shares rebound. Can it continue?

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

CSL Ltd (ASX: CSL) shares have surged 32% over the past month after stronger-than-expected plasma product sales. But with the rally potentially priced in, analysts see better value elsewhere in healthcare.

CSL shares are now trading around $174.80, above the average broker price target. Macquarie has a neutral rating and a target of just over $133, while UBS is more bullish at $181 and Morgan Stanley has a $172 target.

So, where could investors look instead?

Pro Medicus Ltd (ASX: PME)

Pro Medicus shares have endured a brutal 12 months, falling around 43%. But unlike CSL shares, the sell-off hasn’t been accompanied by a deterioration in the company’s underlying growth.

FY26 revenue increased 22.9% to $261.7 million, while underlying EBIT and NPAT climbed 24.4% and 24.1%, respectively.

Its Visage imaging software is already used by major healthcare systems across North America, yet management estimates it has captured only around 11% of the US market. That leaves plenty of room to grow.

Citi has a buy rating and $225 target, implying around 33% upside. Bell Potter is also bullish, with a $226 target, while Barrenjoey has a $210 target. JPMorgan is more cautious with a hold rating and $211 target.

ResMed Inc (ASX: RMD)

ResMed shares have bounced around 25% from their multi-year low in June, but remain down roughly 25% over 12 months. That’s a steeper decline than CSL shares, which still fell 18% over the same period despite their recent rebound.

The sell-off reflected broader pressure on healthcare shares, alongside macroeconomic uncertainty, inflation and cost-of-living concerns. A soft third-quarter update in May added to the pressure.

However, ResMed subsequently delivered a stronger fourth-quarter result, helping restore investor confidence.

The sleep-disorder specialist continues to deliver healthy revenue growth, expanding margins and strong free cash flow. Its third-quarter revenue rose 11% to US$1.4 billion, driven by demand for sleep devices, masks and accessories.

Most brokers rate ResMed shares buy or strong buy. The highest price target of $45.90 implies potential upside of around 46%.

Telix Pharmaceuticals Ltd (ASX: TLX)

Telix Pharmaceuticals operates in a highly specialised healthcare niche: radiopharmaceuticals. Its products combine radioactive isotopes with targeted diagnostics and therapies, helping doctors detect and treat diseases such as cancer with greater precision.

That creates significant barriers to entry and gives Telix shares an interesting growth profile that differs from CSL shares.

In August, Telix reported a 22% year-on-year increase in revenue to US$477 million, putting it towards the upper end of its FY26 guidance.

Brokers are increasingly bullish, with 13 of 16 analysts rating Telix shares buy or strong buy. The average $25.29 target implies roughly 53% upside from $16.50, while the most bullish forecast points to more than 85% potential upside.

For investors looking beyond CSL shares, these three healthcare names could offer considerably more upside.

The post Forget CSL shares. 3 ASX healthcare stocks with bigger upside appeared first on The Motley Fool Australia.

More reading

• $10,000 invested in CSL shares in June is now worth…
• 6 ASX shares tipped by brokers to rise 34% to 87%
• If I invest $10,000 in CSL shares, what passive income will I earn in FY27?
• UBS names its 10 top ASX picks for the next 3-6 months
• Are CSL shares still cheap after almost doubling since June?

Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, ResMed, and Telix Pharmaceuticals. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended CSL, Pro Medicus, and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The All Ordinaries Index (ASX: XAO) has slid lower over the past month as ASX shares are hit by falling investor confidence, concerns about inflation, and interest rate hike fears.

At the time of writing, the All Ords Index is down around 3%.

But at times when confidence is sliding, it’s important to pinpoint shares which could outperform going forward. 

Here are two ASX shares that brokers are tipping to outperform the index over the next 12 months. And they’re forecast to grow by up to 42%.

Superloop Ltd (ASX: SLC)

Superloop is an Australian-based fixed-line internet service provider. It provides broadband services to consumers and businesses across the Asia Pacific region, and wholesale solutions to other downstream internet services entities. 

Its services include Wi-Fi management, mobile services, and National Broadband Network products. The company owns an extensive fiber network and is also a part-owner of the Indigo subsea cable. 

The telco has rapidly expanded in recent years with several large acquisitions. These include Lightning Broadband (an internet service provider) in May 2026, Uecomm (a fiber infrastructure) in 2024, and Exetel (an internet retailer) in 2021.

The company also posted an impressive FY26 earnings result last month. It reported a 21.6% increase in reported revenue, a 33.1% increase in underlying EBITDA, and NPAT of $17.5 million.

At the time of writing, Superloop shares are up around 0.5% for the day to $2.75. For the year-to-date the shares have increased around 8%, but the stock is about 12% lower than 12 months ago. 

Going forward, analysts are very bullish about Superloop’s potential for growth in FY27. Market Index data shows all brokers have a strong buy rating on the ASX telco shares. And the $3.90 average target price implies an upside of around 42%, at the time of writing.

Universal Store Holdings Ltd (ASX: UNI)

Universal Store is an Australian retailer specialising in trend-led and casual men’s and women’s fashion, shoes, accessories, lifestyle, and gifting. 

The company owns a portfolio of popular premium fashion brands like Champion, Perfect Stranger, Tommy Jeans, Kiss Chacey, Thrills, Barney Cools, and others.

The ASX consumer discretionary shares crashed to a two year low in May after a deterioration in trading conditions saw investors quickly sell up their shares. 

The update followed a broad decline in discretionary shares, as geopolitical uncertainty and inflation concerns prompted an investor rotation towards more defensive sectors.

At the time of writing, Universal Store shares are down around 2% and changing hands at $7.62 each. For the year-to-date, the shares are down around 6% and 13% lower than 12 months ago.

But the experts appear to be confident that we’ll see a turnaround in the coming months. Market Index data shows all brokers have a strong buy rating on the shares, and the $9.67 average target price implies a potential 25% upside at the time of writing.

The post 2 ASX shares tipped by brokers to return 25% and 42% appeared first on The Motley Fool Australia.

More reading

• How much is needed in superannuation for $3,000 in weekly passive income?
• 3 stellar ASX dividend stocks to supplement your superannuation 
• Why investors should be targeting ASX mid-caps and ASX small-caps after earnings season: Expert
• 3 top ASX dividend shares to buy in September
• 2 ASX dividend shares with yields above 7%

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Universal Store. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Many Australians may love the idea of receiving $80,000 a year of passive income and choosing to retire at the age of 50. Investing in ASX shares could be the best way to achieve that.

For some Aussies, retiring early could be appealing because it could mean enjoying more of life, calling it quits before the body can’t do the physical work any more, or just getting away from the desk and out into ‘life’.

Whatever the motivation for wanting to unlock $80,000 of annual passive income, reaching that goal could be very compelling.

Use compounding to build wealth

I think that every investor should keep the power of compounding in mind for long-term wealth creation.

One of the smartest people ever to live, Albert Einstein, once reportedly said:

Compound interest is the eighth wonder of the world. He who understands it, earns it; he who doesn’t, pays it.

By using compounding, we can invest in ASX shares that grow in value on their own. We don’t need to contribute any further money ourselves to see that growth in value.

Let’s look at two scenarios of how that could play out for someone.

Imagine someone is 20 right now and they manage to save $750 per month to invest in ASX shares. That translates into an annual investment total of $9,000. If we assume the portfolio returns an average of 10%, the portfolio would be worth $1.48 million after 30 years.

In another example, let’s consider someone who starts five years later at 25, so they can earn more and they can save $1,500 per month. If the portfolio returned the same 10% per year, it would grow to be worth an incredible $1.77 million.

Which ASX shares investors could buy for passive income to retire

If we go with the two example portfolios above, a $1.48 million portfolio would require a dividend yield of 5.4% to make $80,000 of annual passive income. Meanwhile, the $1.77 million portfolio would require a dividend yield of 4.5%.

There are a wide variety of investments that we can make to generate high passive income.

I’ll run through some businesses and other types of businesses that could be great options for a portfolio dividend yield of around 5%.

Firstly, I’ll highlight investment businesses such as Washington H. Soul Pattinson and Co. Ltd (ASX: SOL), Australian Foundation Investment Co Ltd (ASX: AFI), Australian United Investment Company Ltd (ASX: AUI), Future Generation Australia Ltd (ASX: FGX), PM Capital Global Opportunities Fund Ltd (ASX: PGF) and L1 Long Short Fund Ltd (ASX: LSF).

There are operating businesses like Telstra Group Ltd (ASX: TLS), Wesfarmers Ltd (ASX: WES), Lovisa Holdings Ltd (ASX: LOV), Medibank Private Ltd (ASX: MPL) and JB Hi-Fi Ltd (ASX: JBH) that could all be compelling options.

Other top options for passive income include Charter Hall Long WALE REIT (ASX: CLW), Centuria Industrial REIT (ASX: CIP), Dexus Industria REIT (ASX: DXI), Rural Funds Group (ASX: RFF) and WCM Quality Global Growth Fund (ASX: WCMQ).

I think investors wanting to retire with $80,000 of annual passive income would be well-served by the above names, as well as other ASX shares that could deliver strong growth.

The post How much do I need to retire on $80,000 a year at 50? appeared first on The Motley Fool Australia.

More reading

• Is the Telstra share price a buy for its 6.25% dividend yield?
• What happens if the ASX share market crashes just after I retire?
• How much passive income could a $500,000 superannuation balance generate?
• Top 3 ASX shares to buy with $3,000 in September
• Which ASX shares win when the Aussie dollar is strong?

Motley Fool contributor Tristan Harrison has positions in Future Generation Australia, L1 Long Short Fund, Rural Funds Group, Washington H. Soul Pattinson and Company Limited, and Wcm Quality Global Growth Fund. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Lovisa, Washington H. Soul Pattinson and Company Limited, and Wesfarmers. The Motley Fool Australia has positions in and has recommended Rural Funds Group, Telstra Group, and Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia has recommended Lovisa and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The S&P/ASX 200 Index (ASX: XJO) endured a tough session this Tuesday, sending the value of many ASX shares sharply lower. After yesterday’s lukewarm start to the trading week, investors turned decisively negative today, with the ASX 200 starting in red territory and getting progressively worse over the session.

By the time the closing bell rang, the index had lost a flat 1%, leaving it at 8,920.8 points.

The American markets were closed last night for the Labor Day holiday, so Friday’s losses are our last point of reference. Let’s see what they do later tonight.

So let’s get back to the local markets now and take stock of how the different ASX sectors traversed the tough trading conditions that we saw this Tuesday.

Winners and losers

Despite the broader market’s sharp drop, there were a few sectors that escaped with a rise.

But first, it was consumer discretionary stocks that copped the worst of it this Tuesday. The S&P/ASX 200 Consumer Discretionary Index (ASX: XDJ) had an awful time, plunging 1.88%.

Tech shares weren’t much better, with the S&P/ASX 200 Information Technology Index (ASX: XIJ) cratering 1.76%.

Financial stocks were also in that ballpark. The S&P/ASX 200 Financials Index (ASX: XFJ) ended up diving 1.63%.

Real estate investment trusts (REITs) weren’t popular either, evident by the S&P/ASX 200 A-REIT Index (ASX: XPJ)’s 1.46% slump.

Consumer staples shares were no safe haven. The S&P/ASX 200 Consumer Staples Index (ASX: XSJ) retreated 1.31% this session.

Nor were industrial stocks, with the S&P/ASX 200 Industrials Index (ASX: XNJ) sinking 0.74%.

Communications shares were right behind that. The S&P/ASX 200 Communication Services Index (ASX: XTJ) dipped 0.73% this Tuesday.

Mining stocks couldn’t escape the selling, illustrated by the S&P/ASX 200 Materials Index (ASX: XMJ)’s 0.57% slide.

The same can be said for our last losers, gold shares. The All Ordinaries Gold Index (ASX: XGD) ended up slipping 0.22%.

Let’s get to the green sectors now. At the front of that line were utilities stocks, with the S&P/ASX 200 Utilities Index (ASX: XUJ) jumping 0.59% today.

Healthcare stocks displayed some strong vitals too. The S&P/ASX 200 Healthcare Index (ASX: XHJ) ended up galloping 0.45% higher.

Finally, energy stocks got over the line, as you can see from the S&P/ASX 200 Energy Index (ASX: XEJ)’s 0.22% improvement.

Top 10 ASX 200 shares countdown

Gold stock Predictive Discovery Ltd (ASX: PDI) was our best index performer this Tuesday. Predictive shares beat out some uninspired competition to close 3.76% higher at $4.69.

Despite this market-bucking gain, there wasn’t any fresh news out from the company to explain it.

Here’s how the other winners pulled up at the kerb this session:

ASX-listed company	Share price	Price change
Predictive Discovery Ltd (ASX: PDI)	$4.69	3.76%
Downer EDI Ltd (ASX: DOW)	$6.66	3.10%
Elevra Lithium Ltd (ASX: ELV)	$7.75	2.92%
Mesoblast Ltd (ASX: MSB)	$2.29	2.69%
South32 Ltd (ASX: S32)	$5.22	2.05%
FireFly Metals Ltd (ASX: FFM)	$1.82	1.96%
NRW Holdings Ltd (ASX: NWH)	$7.86	1.95%
Centuria Capital Group (ASX: CNI)	$1.31	1.95%
Viva Energy Group Ltd (ASX: VEA)	$2.98	1.56%
Karoon Energy Ltd (ASX: KAR)	$1.81	1.69%

Our top 10 shares countdown is a recurring end-of-day summary that shows which companies made big moves on the day. Check in at Fool.com.au after the weekday market closes to see which stocks make the countdown.

The post Here are the top 10 ASX 200 shares today appeared first on The Motley Fool Australia.

More reading

• 6 ASX shares tipped by brokers to rise 34% to 87%
• 3 ASX healthcare shares to buy with 25% to 100% upside as sector rebound races higher
• The ASX 200 has dropped to a 3-day low. Here’s what’s happening
• Are NAB, ANZ, Westpac and CBA shares attractive buys right now?
• 5 things to watch on the ASX 200 on Tuesday

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX All Ords Index (ASX: XAO) shares are 0.9% lower at 9,115.5 points on Tuesday.

With earnings season over, brokers have updated their ratings and 12-month price targets on hundreds of ASX shares.

Here are six stocks with strong upside potential.

NextDC Ltd (ASX: NXT)

The NextDC share price is $12.46, down 2.3% today.

Over the past month, this ASX tech share has fallen 14%.

UBS has a buy rating on NextDC shares with a $23.45 target.

This suggests a potential 88% upside ahead.

Nine Entertainment Co. Holdings Ltd (ASX: NEC)

The Nine Entertainment share price is 86 cents, down 3.2% today.

Over the past month, this ASX communications share has dropped 15%.

Morgan Stanley has a buy rating on Nine shares with a 12-month target of $1.40.

This suggests a potential 63% upside ahead.

Qantas Airways Ltd (ASX: QAN)

The Qantas share price is $9.30, down 0.3% today.

This ASX travel share has fallen 11% over the past month.

Morgan Stanley has a buy rating on Qantas shares with a $12.80 target.

This implies potential capital growth of 38% over the next year.

Centuria Capital Group (ASX: CNI)

The Centuria Capital Group share price is $1.33, up 3.7% today.

Over the past month, this ASX real estate investment trust (REIT) has fallen 11%.

MA Financial Group has a buy recommendation on Centuria Capital Group shares with a $1.83 target.

This indicates potential capital gains of 38% over the next year. 

Paladin Energy Ltd (ASX: PDN)

The Paladin Energy share price is $11.61, down 0.9% today.

Over the past month, this ASX uranium share has spiked 12%.

Canaccord Genuity has a buy call on Paladin Energy shares with a $15.80 target.

This suggests a potential 36% upside ahead.

Pro Medicus Ltd (ASX: PME)

The Pro Medicus share price is $168.81, up 0.1% today.

Over the past month, this ASX healthcare share has fallen 4%.

Bell Potter has a buy rating on Pro Medicus shares with a $226 target.

This indicates capital gains of 34% over the next year. 

In a note, the broker commented:

PME reported FY26 revenue and EBIT growth of 23% and 26% respectively with the result at EBIT modestly (1.5%) ahead of consensus earnings.

As the revenue base of the group expands the top line growth is decelerating, however, margin expansion continues and this drove the small earnings beat.

FY26 EBIT margin expanded by a further 190bps to 75% and is likely to continue at this rate for the foreseeable future.

The post 6 ASX shares tipped by brokers to rise 34% to 87% appeared first on The Motley Fool Australia.

More reading

• Uranium is back. Three ASX shares that give you exposure
• Here’s the dividend forecast out to 2029 for Qantas shares
• Down 43%! 4 reasons to buy the BIG dip in Pro Medicus shares today
• Experts name 3 top ASX shares to buy this week
• Buy, hold, sell: Pro Medicus, BHP, CBA shares

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Ma Financial Group, Nine Entertainment, and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Oil prices are back in the spotlight, and Goldman Sachs thinks they could stay higher for longer than previously expected.

Brent crude is trading around US$97 a barrel today, while West Texas Intermediate (WTI) crude is near US$93.

That puts oil close to its highest level in around 3 months amid renewed fighting in the Middle East.

And despite some signs that supply conditions are improving, Goldman Sachs has now lifted its oil price forecasts for 2027.

So, how high does the investment bank think oil could go?

Goldman lifts its forecast

According to The Australian, Goldman Sachs co-head of global commodities Daan Struyven now expects Brent crude to average around US$80 a barrel next year.

That is US$5 higher than the bank’s previous forecast, although it’s still well below the US$97 level Brent is trading at today.

The reason Goldman isn’t expecting oil to stay this high is that the hit to global supply has not been quite as bad as first feared.

Commercial oil inventories in developed economies have “barely drawn” since the fighting began. Instead, much of the shortfall has been covered by strategic reserves, oil already at sea and stockpiles in China.

There have also been signs that production is recovering.

In April, output from Gulf producers was around 14.3 million barrels per day below pre-war levels. By July, Goldman estimates that gap had narrowed to around 8 million barrels per day.

Oil could still go much higher

Keep in mind, there’s still plenty that could send oil prices above Goldman’s base case.

Around 7 million barrels per day of crude oil and refined products reportedly continue to move through the Strait of Hormuz.

That makes any further disruption to the important shipping route something investors will be watching closely.

Goldman’s own scenarios show just how wide the range of possible outcomes still is.

If Gulf production continues to be heavily disrupted, the bank believes Brent could climb above US$120 a barrel.

On the other hand, if supply conditions improve faster than expected, prices could fall back into the low US$60’s.

Not only that, but there could also be some relief later on. New pipelines are expected to come online in late 2027, which should make it easier to move oil around the region.

What does it mean for investors?

Oil has already had a massive run.

Trading Economics shows WTI crude has climbed roughly 49% over the past 12 months, while Brent is up around 47%.

That has been a big tailwind for oil producers, including a number of ASX-listed energy stocks such as Woodside Ltd(ASX: WDS) and Santos Ltd (ASX: STO).

But with Brent now trading around US$97 a barrel, Goldman’s US$80 forecast suggests a decent pullback could be coming next year.

Obviously, that could weigh on oil stocks, so I’d be cautious about chasing ASX energy shares after the recent rally.

The post Could oil stay near US$100? Goldman Sachs just changed its forecast appeared first on The Motley Fool Australia.

More reading

• Top 3 ASX shares to buy with $3,000 in September
• Santos shares on watch after major Papua LNG deal
• 5 things to watch on the ASX 200 on Tuesday
• $10,000 a year in passive income buying just $10k worth of ASX shares? Here’s how I’d go about it
• These ASX shares benefit from a high Aussie dollar

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.